Your Complete Wegovy Cost & Timeline Breakdown
How Long Does It Take for Wegovy to Suppress Appetite During Initial Treatment?
Most patients begin experiencing appetite suppression within 2-4 weeks of starting Wegovy, though the timeline varies between individuals. The prescription-only medicine works by mimicking GLP-1, a natural hormone that signals fullness to your brain. During the initial 0.25mg dose (weeks 1-4), costing £79.99 monthly, you may notice reduced cravings and earlier satiety after meals. Some patients report feeling less hungry between meals within the first week, whilst others require the full month to experience noticeable changes.
The gradual dose escalation is designed to minimise side effects whilst allowing your body to adapt to the medication's appetite-suppressing effects. As you progress through the escalation schedule, the appetite suppression typically becomes more pronounced. This careful approach ensures optimal tolerability whilst building towards the therapeutic maintenance dose of 2.4mg.
Monthly Cost Breakdown: How Long Does It Take for Wegovy to Suppress Appetite at Each Dose?
Understanding both the appetite suppression timeline and associated costs helps you budget effectively for Wegovy treatment. The 0.25mg starter dose costs £79.99 monthly and provides initial appetite reduction within 2-4 weeks. Progressing to 0.5mg (weeks 5-8) costs £94.99 monthly, where most patients report more consistent appetite control. The 1mg dose (weeks 9-12) at £99.99 monthly typically delivers sustained appetite suppression throughout the day.
The 1.7mg dose (weeks 13-16) costs £139.99 monthly and often represents a turning point where patients experience significant appetite reduction. Finally, the maintenance 2.4mg dose at £209.99 monthly provides optimal appetite suppression for long-term weight management. Returning customers benefit from code DOSE25 applied at checkout, ensuring predictable monthly costs throughout their treatment journey.
Clinical Evidence: How Long Does It Take for Wegovy to Suppress Appetite in STEP Trials?
The landmark STEP clinical trials provide valuable insights into Wegovy's appetite suppression timeline. In STEP 1, published by Wilding et al. in NEJM 2021, patients taking Wegovy alongside diet and exercise reported appetite changes within the first month of treatment. The study demonstrated that appetite suppression contributed to the average clinically studied weight loss observed at 68 weeks compared to 2.4% with placebo.
STEP 2 showed similar appetite suppression patterns in patients with type 2 diabetes, whilst STEP 3 combined Wegovy with intensive behavioural therapy. These trials consistently showed that appetite reduction begins during the dose escalation phase and strengthens as patients reach higher doses, supporting the importance of completing the full 16-week escalation schedule.
How Wegovy Works: The Science Behind Appetite Suppression Timing
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone. When injected once weekly using the FlexTouch pen, semaglutide binds to GLP-1 receptors in your brain's appetite control centres. This action slows gastric emptying, meaning food stays in your stomach longer, promoting feelings of fullness after smaller meals. The medication also directly influences hypothalamic appetite centres, reducing food cravings and the drive to eat. Additionally, Wegovy may enhance insulin sensitivity and improve blood sugar control, which can further support appetite regulation and reduce cravings for high-calorie foods.
Ordering Process: Starting Your Appetite Suppression Journey
Beginning Wegovy treatment through EverydayMeds involves a streamlined 3-minute online clinical assessment covering your medical history and weight management goals. Our qualified prescribers review your assessment within 3 working days (or 24 hours with express service), ensuring Wegovy is clinically appropriate for your situation. Once approved, your prescription-only medicine ships via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity. Our GPhC-registered pharmacy (#9012878) ensures all medications meet UK pharmaceutical standards. You'll receive detailed injection instructions and storage guidance with your first order, plus access to ongoing clinical support throughout your treatment.
Storage and Practical Considerations for Optimal Appetite Suppression
Proper storage ensures Wegovy maintains its appetite-suppressing potency throughout treatment. Store unopened pens in your fridge at 2-8°C, though they remain stable for up to 6 weeks at room temperature below 30°C once removed from refrigeration. This storage flexibility makes Wegovy ideal for travel compared to alternatives with shorter room-temperature stability. The FlexTouch pen delivers pre-set doses accurately, eliminating guesswork during the critical escalation phase. Inject once weekly on the same day, rotating between your thigh, upper arm, or abdomen to prevent injection site reactions that might interrupt your treatment schedule. Never skip doses or accelerate the escalation timeline, as this may compromise both safety and appetite suppression effectiveness.
Long-term Monthly Cost Planning: Sustained Appetite Suppression with Wegovy
Planning for sustained appetite suppression requires understanding long-term monthly costs beyond the initial 16-week escalation. The maintenance 2.4mg dose costs £209.99 monthly with DOSE25 discount code, representing an annual investment of approximately £2,520 for ongoing appetite control. Our Ultimate Stability Trio provides three months of maintenance supply for £649.99, offering convenience through fewer orders and Stock Available availability.
Consider that appetite suppression with Wegovy requires ongoing treatment, as clinical evidence shows patients typically regain approximately two-thirds of lost weight within one year of stopping treatment. This makes monthly budgeting essential for long-term success, positioning the £209.99 monthly maintenance cost as an investment in sustained weight management rather than a short-term expense.
Maximising Value: How Long Does It Take for Wegovy to Suppress Appetite Cost-Effectively?
Achieving cost-effective appetite suppression with Wegovy involves strategic ordering and understanding discount opportunities. New customers applying code FIRST40 at checkout reduce their initial treatment costs, whilst DOSE25 ensures returning customers maintain competitive pricing throughout long-term treatment. Our Getting Started bundles, such as the Intro Duo (0.25mg & 0.5mg) for £169.99, provide convenient two-month starter packages with Reliable Supply continuity. The Progress Trio (0.5mg, 1mg & 1.7mg) at £369.99 covers three crucial escalation months where appetite suppression typically strengthens. Consider that achieving optimal appetite suppression requires completing the full dose escalation, making bundle options valuable for maintaining treatment continuity. Our clinical team at GPhC #9012878 can advise on ordering patterns that balance cost-effectiveness with therapeutic outcomes, ensuring you achieve sustained appetite control without treatment interruptions. Start your Wegovy journey today with transparent monthly pricing and expert clinical support.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
